BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14628202)

  • 1. Cell type selective accumulation of mercaptoundecahydro- closo-dodecaborate (BSH) in glioblastoma multiforme.
    Neumann M; Bergmann M; Gabel D
    Acta Neurochir (Wien); 2003 Nov; 145(11):971-5. PubMed ID: 14628202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the subcellular distribution of mercaptoundecahydro-closo-dodecaborate (BSH) in human glioblastoma multiforme by electron microscopy.
    Neumann M; Kunz U; Lehmann H; Gabel D
    J Neurooncol; 2002 Apr; 57(2):97-104. PubMed ID: 12125978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium mercaptoundecahydro-closo-dodecaborate (BSH), a boron carrier that merits more attention.
    Wittig A; Stecher-Rasmussen F; Hilger RA; Rassow J; Mauri P; Sauerwein W
    Appl Radiat Isot; 2011 Dec; 69(12):1760-4. PubMed ID: 21420870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron neutron capture therapy: long-term effects on the skin and spinal cord of the rat.
    Morris GM; Constantine G; Ross G; Yeung TK; Hopewell JW
    Radiat Res; 1993 Sep; 135(3):380-6. PubMed ID: 8378531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma.
    Kageji T; Nagahiro S; Kitamura K; Nakagawa Y; Hatanaka H; Haritz D; Grochulla F; Haselsberger K; Gabel D
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):120-30. PubMed ID: 11516861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPA.
    Garabalino MA; Heber EM; Monti Hughes A; Pozzi EC; Molinari AJ; Nigg DW; Bauer W; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2014 Jun; 88():64-8. PubMed ID: 24360859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution of (10)B for Boron Neutron Capture Therapy (BNCT) in a mouse model after injection of sodium mercaptoundecahydro-closo-dodecaborate and l-para-boronophenylalanine.
    Wittig A; Huiskamp R; Moss RL; Bet P; Kriegeskotte C; Scherag A; Hilken G; Sauerwein WA
    Radiat Res; 2009 Oct; 172(4):493-9. PubMed ID: 19772470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma.
    Haselsberger K; Radner H; Pendl G
    Neurosurgery; 1996 Aug; 39(2):321-5; discussion 325-6. PubMed ID: 8832669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of 10B in the central degenerative areas of human glioma and colon carcinoma spheroids after sulfhydryl boron hydride administration.
    Pettersson OA; Carlsson J; Grusell E
    Cancer Res; 1992 Mar; 52(6):1587-91. PubMed ID: 1540968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with buthionine sulfoximine enhanced uptake and retention of BSH in brain tumor.
    Yoshida F; Yamamoto T; Nakai K; Zaboronok A; Matsuda M; Akutsu H; Ishikawa E; Shirakawa M; Matsumura A
    Appl Radiat Isot; 2014 Jun; 88():86-8. PubMed ID: 24731546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
    Suzuki M; Masunaga S; Kinashi Y; Nagata K; Sakurai Y; Nakamatsu K; Nishimura Y; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):260-6. PubMed ID: 15093923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy of brain tumors: investigation of urinary metabolites and oxidation products of sodium borocaptate by electrospray ionization mass spectrometry.
    Gibson CR; Staubus AE; Barth RF; Yang W; Kleinholz NM; Jones RB; Green-Church K; Tjarks W; Soloway AH
    Drug Metab Dispos; 2001 Dec; 29(12):1588-98. PubMed ID: 11717178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
    Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boron neutron capture therapy: boron biodistribution and pharmacokinetics of Na2B12H11SH in patients with glioblastoma.
    Haselsberger K; Radner H; Pendl G
    Cancer Res; 1994 Dec; 54(24):6318-20. PubMed ID: 7987820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer.
    Ichikawa H; Taniguchi E; Fujimoto T; Fukumori Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S111-4. PubMed ID: 19376721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats.
    Mehta SC; Boudinot FD; Lu DR
    Drug Metab Dispos; 1995 Dec; 23(12):1368-71. PubMed ID: 8689945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
    Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
    Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy.
    Kageji T; Nagahiro S; Otersen B; Gabel D; Nakaichi M; Nakagawa Y
    J Neurooncol; 2002 Sep; 59(2):135-42. PubMed ID: 12241106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.